Moustapha Hassan
Professor
Biology
Karolinska University Hospital
Sweden
Biography
Professor Moustapha Hassan is currently director of Preclinical Laboratory, the preclinical research facility at Karolinska University Hospital, Huddinge, Sweden, as well as Professor of Transplantation Research at Karolinska Institutet Huddinge, Stockholm, Sweden. He is a consultant to several hospitals in Sweden and many hospitals in Europe for personalized treatment prior to stem cell transplantation and treatment for hematological malignancies. His particular focus has been on increasing treatment efficacy and reducing side effects for transplanted children, and on optimizing treatment with busulfan/cyclophosphamide in stem cell transplantation. Professor Hassan developed a liposomal formulation enabling intravenous administration which is currently undergoing clinical trials. Professor Hassan’s current research projects focus on personalizing treatment through genome analysis, nanomedicine and improvement in pre-transplant medicine. Professor Moustapha Hassan is currently director of Preclinical Laboratory, the preclinical research facility at Karolinska University Hospital, Huddinge, Sweden, as well as Professor of Transplantation Research at Karolinska Institutet Huddinge, Stockholm, Sweden. He is a consultant to several hospitals in Sweden and many hospitals in Europe for personalized treatment prior to stem cell transplantation and treatment for hematological malignancies. His particular focus has been on increasing treatment efficacy and reducing side effects for transplanted children, and on optimizing treatment with busulfan/cyclophosphamide in stem cell transplantation. Professor Hassan developed a liposomal formulation enabling intravenous administration which is currently undergoing clinical trials. Professor Hassan’s current research projects focus on personalizing treatment through genome analysis, nanomedicine and improvement in pre-transplant medicine.
Research Interest
Personalizing treatment through genome analysis, nanomedicine and improvement in pre-transplant medicine.
